{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:18:23Z","timestamp":1790803103012,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["EK2022ZX05"],"award-info":[{"award-number":["EK2022ZX05"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22Y11907100"],"award-info":[{"award-number":["22Y11907100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.11.063","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:36:17Z","timestamp":1669970177000},"page":"427-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Common issues and improvement solution of vaccine hesitancy in children with underlying neurological conditions: Experience from one National Children\u2019s Medical Center in China"],"prefix":"10.1016","volume":"41","author":[{"given":"Tianxing","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.11.063_b0005","unstructured":"China NHCotPsRo. Implementation of the Expanded National Immunization Program 2008. Available from: http:\/\/www.nhc.gov.cn\/bgt\/pw10803\/200805\/06e538cad856458bba92730b81e0f29c.shtml."},{"issue":"06","key":"10.1016\/j.vaccine.2022.11.063_b0010","first-page":"601","article-title":"Reported coverage of vaccines in the National Immunization Program of China, 2015","volume":"23","author":"Jian","year":"2017","journal-title":"Chin J Vaccines Immunization"},{"key":"10.1016\/j.vaccine.2022.11.063_b0015","unstructured":"Kroger A BL, Hunter P. General Best Practice Guidelines for Immunization. Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). 2021 [cited. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/index.html."},{"issue":"Suppl 7","key":"10.1016\/j.vaccine.2022.11.063_b0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/epi.12306","article-title":"Epilepsy and vaccinations: Italian guidelines","volume":"54","author":"Pruna","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.vaccine.2022.11.063_b0025","unstructured":"China NHCotPsRo. National immunization program vaccine children\u2019s immunization procedures and instructions 2021 2021."},{"issue":"6","key":"10.1016\/j.vaccine.2022.11.063_b0030","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1586\/14760584.2014.897615","article-title":"Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations","volume":"13","author":"Richter","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2022.11.063_b0035","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000001323","article-title":"Immunizing Patients With Adverse Events After Immunization and Potential Contraindications to Immunization: A Report From the Special Immunization Clinics Network","volume":"35","author":"Top","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"15","key":"10.1016\/j.vaccine.2022.11.063_b0040","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.vaccine.2021.03.009","article-title":"Vaccine coverage among children with epilepsy in two Canadian provinces: A Canadian immunization research network study","volume":"39","author":"Righolt","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.063_b0045","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1186\/s12889-019-7106-5","article-title":"Vaccine Coverage among Children with and without Intellectual Disabilities in the UK: Cross Sectional Study","volume":"19","author":"Emerson","year":"2019","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2022.11.063_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/jpc.12097","article-title":"Immunisation coverage in children with cerebral palsy compared with the general population","volume":"49","author":"Greenwood","year":"2013","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.063_b0055","first-page":"42","article-title":"Investigation on immunization program coverage rate and its safety in children with tuberous sclerosis","volume":"55","author":"Gao","year":"2017","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.vaccine.2022.11.063_b0060","unstructured":"China NHCotPsRo. National immunization program vaccine children\u2019s immunization procedures and instructions 2016 2016. Available from: http:\/\/www.nhc.gov.cn\/jkj\/s3581\/201701\/a91fa2f3f9264cc186e1dee4b1f24084.shtml."},{"issue":"45","key":"10.1016\/j.vaccine.2022.11.063_b0065","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1016\/j.vaccine.2014.09.003","article-title":"Vaccination recommendations for patients with neuromuscular disease","volume":"32","author":"Esposito","year":"2014","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2022.11.063_b0085","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1016\/j.vaccine.2018.03.063","article-title":"Vaccine hesitancy around the globe: Analysis of three years of WHO\/UNICEF Joint Reporting Form data-2015-2017","volume":"36","author":"Lane","year":"2018","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.063_b0090","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa003077","article-title":"The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine","volume":"345","author":"Barlow","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2022.11.063_b0095","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1542\/peds.2008-0939","article-title":"Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures","volume":"121","author":"Steering Committee on Quality Improvement and Management SoFSAAoP","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.063_b0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0009922816649001","article-title":"Parents' Perspectives on How to Improve the Childhood Vaccination Process","volume":"56","author":"Lieu","year":"2017","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.063_b0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00431-021-04219-4","article-title":"Evaluation of immunization status in patients with cerebral palsy: a multicenter CP-VACC study","volume":"181","author":"Bozkaya-Yilmaz","year":"2022","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2022.11.063_b0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fped.2019.00084","article-title":"Vaccination Status of Children With Epilepsy or Cerebral Palsy in Hunan Rural Area and a Relative KAP Survey of Vaccinators","volume":"7","author":"Yang","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.vaccine.2022.11.063_b0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejpn.2021.12.006","article-title":"Movement disorders, cerebral palsy and vaccination","volume":"36","author":"Liba","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.vaccine.2022.11.063_b0120","unstructured":"Administration CNMP. Database of vaccine instructions and labels [updated 2021-11-29]. Available from: http:\/\/app1.nmpa.gov.cn\/data_nmpa\/face3\/base.jsp?tableId=174&tableName=TABLE174&title=%D2%DF%C3%E7%CB%B5%C3%F7%CA%E9%BA%CD%B1%EA%C7%A9%CA%FD%BE%DD%BF%E2%A3%A8%B2%E2%CA%D4%B0%E6%A3%A9&bcId=163377767229317198264330670647."},{"issue":"29","key":"10.1016\/j.vaccine.2022.11.063_b0125","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1016\/j.vaccine.2017.05.021","article-title":"Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008\u20132013","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2022.11.063_b0130","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.vaccine.2013.11.107","article-title":"Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005\u20132012","volume":"32","author":"Liu","year":"2014","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2022.11.063_b0135","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.vaccine.2018.04.038","article-title":"Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012\u20132016","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.063_b0140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.vaccine.2012.11.051","article-title":"Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China","volume":"31","author":"Guo","year":"2013","journal-title":"Vaccine"},{"issue":"09","key":"10.1016\/j.vaccine.2022.11.063_b0145","first-page":"699","article-title":"Expert consensus on the long-term management of epilepsy in children","volume":"51","author":"Department of Neurology PSoCMA","year":"2013","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"34","key":"10.1016\/j.vaccine.2022.11.063_b0075","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1016\/j.vaccine.2011.02.099","article-title":"Immunization coverage and timeliness of vaccination in Italian children with chronic diseases","volume":"30","author":"Pandolfi","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.063_b0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.pop.2020.05.002","article-title":"Improving Immunization Coverage in Special Populations","volume":"47","author":"Stephens","year":"2020","journal-title":"Prim Care"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22014864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22014864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:22:50Z","timestamp":1759404170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22014864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22014864"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common issues and improvement solution of vaccine hesitancy in children with underlying neurological conditions: Experience from one National Children\u2019s Medical Center in China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}